Publications by authors named "D R Radin"

Claim this Profile
L
Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trial.
Daniel P Radin, Rok Cerne, Jodi L Smith, Jeffrey M Witkin, Arnold Lippa

Eur J Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma.
Sophie G Shifman, Jennifer L O'Connor, Daniel P Radin, Aryan Sharma, Laura Infante

J Exp Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia.
Daniel P Radin, Rok Cerne, Jodi L Smith, Jeffrey M Witkin, Arnold Lippa

J Psychiatr Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a continued need for behavioral pharmacology in the discovery and development of medicines?
Jeffrey M Witkin, Jodi L Smith, Daniel P Radin

J Pharmacol Exp Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPA Receptor Modulation in the Treatment of High-Grade Glioma: Translating Good Science into Better Outcomes.
Daniel P Radin

Pharmaceuticals (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis